Medicare is reimbursing for the generic drug Vascepa that meets RLD guidelines. These guidelines include 1000 mg capsules of Icospaent Ethyl not 600-800 mg Icosapent Ethyl capsules as Hikma clearly admits to in MSDS here: file:///C:/Users/AC-SWAS-CS-RDTRP-H/Downloads/Icosapent%20Ethyl%20Capsules%20-%20SDS.pdf
Hikma has knowingly launched a mislabeled drug into commerce, keep the "medication" as evidence.
If you do receive the generic version you should report the fraud to Medicare at the above listed number.